Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
Taofeek K. Owonikoko, MD, PhD, MS / Ticiana Leal, MD - New Frontiers in Small Cell Lung Cancer: Getting Ready for the Emergence of B7-H3–Directed ADCs
|
Dec 12, 2025 |
|
Nicola Hanania, MD, MS / Surya P. Bhatt, MD, MSPH - Demystifying the Evidence for Biologics in COPD: Strategies for Optimized, Patient-Centered Management
|
Dec 11, 2025 |
|
Mark Awad, MD, PhD / Carl M. Gay, MD, PhD - Breaking News in Small-Cell Lung Cancer: Expert Insights on B7-H3–Directed Antibody–Drug Conjugates From Recent Congresses
|
Dec 01, 2025 |
|
Luis Paz-Ares, MD, PhD / Lauren Averett Byers, MD - Shaping the Future of SCLC Treatment: Advancing Care Through Innovative Approaches
|
Nov 24, 2025 |
|
Anne K. Ellis, MD, MSc, FRCPC / Andrew Thamboo, MD, FRCSC / Meyer Balter, MD, FRCPC - Advancing CRSwNP Care: Multidisciplinary Insights on Early Detection and the Role of Biologic Therapies
|
Nov 21, 2025 |
|
Luis Paz-Ares, MD, PhD / Kristin Higgins, MD - Creating a Roadmap to Optimize Care for Patients With LS-SCLC: Integrating the Evidence Into Practical Care
|
Oct 30, 2025 |
|
MeiLan Han, MD, MS / Eddie Needham, MD, FAAFP / Valerie Chang - COPD Primary Care Playbook: Boosting Diagnosis, Treatment, and Therapy Escalation for Optimal Disease Control
|
Oct 17, 2025 |
|
Stephanie Christenson, MD, MAS - Beyond Standard Care: Enhancing Disease Control With Biologic Therapy for Eosinophilic COPD
|
Sep 24, 2025 |
|
Raffaele Califano, MD / Nicolas Girard, MD, PhD / Antonio Passaro, MD, PhD - Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes
|
Sep 10, 2025 |
|
Matthew W. Martinez, MD, FACC, FASE / Brad Mehl, MHA, ACS, RDCS, RVT, RDMS, RT(R), FASE - The Echo Quest: Conquering Real-World Hypertrophic Cardiomyopathy Cases From Diagnosis to Treatment
|
Sep 09, 2025 |
|
Scott Solomon, MD - Mapping the Future of Heart Failure Care: The Evolving Role of Nonsteroidal MRAs in the Treatment of Patients With Heart Failure and Mildly Reduced/Preserved Ejection Fraction
|
Sep 01, 2025 |
|
Luis Paz-Ares, MD, PhD / Niels Reinmuth, MD, PhD - Developing a Master Plan for ES-SCLC: A Practical Guide to Elevate Care in the Real-World
|
Jul 28, 2025 |
|
Barbara Burtness, MD - The Pan-Tumor Perspective: Looking Toward the Future of Care With HER3-Directed ADCs for Pretreated Patients With Advanced Solid Tumors
|
Jul 01, 2025 |
|
Mark A. Socinski, MD - Global Perspectives on Biomarker Testing in NSCLC: Clinical Insights on Optimizing Implementation in Practice
|
Jun 24, 2025 |
|
David E. Griffith, MD - Guiding Principles in the Management of Refractory Mycobacterium Avium Complex (MAC) Pulmonary Disease: Casing the Evidence to Inform Practical Care
|
Apr 07, 2025 |
|
Jai Radhakrishnan, MD, MS - IgA Nephropathy in Focus: Novel Treatment Strategies for Nephrologists and PCPs
|
Jan 03, 2025 |
|
Pasi A. Jänne, MD, PhD - Expanding Pathways of Care for HER2-Positive Metastatic NSCLC: Beyond Mutation to Overexpression
|
Jan 02, 2025 |
|
Arzu Yorgancioglu, MD - A Global Approach to Asthma Management: Examining Biologics
|
Jan 02, 2025 |
|
Stella Lee, MD - Biologic Therapies for Chronic Rhinosinusitis With Nasal Polyps: Practical, Patient-Centered Perspectives for Providers
|
Dec 12, 2024 |
|
David Harpole, MD / Alfredo Addeo, MD - The Possibilities of Perioperative: Assessing the Use of Perioperative Immunotherapy for Resectable NSCLC
|
Dec 12, 2024 |
|
Csaba P. Kovesdy, MD - Integrating Nonsteroidal MRAs in Practice: A Guideline-Driven Approach to the Management of CKD and T2D
|
Nov 29, 2024 |
|
David Harpole, MD / Neel Chudgar, MD - The Practicalities of Perioperative Immunotherapy for Resectable NSCLC
|
Nov 26, 2024 |
|
David Harpole, MD / Nicolas Girard, MD, PhD - Trials and Tribulations: Examining the Data for Perioperative Immunotherapeutic Approaches in Resectable NSCLC
|
Nov 20, 2024 |
|
Stephanie A. Christenson, MD, MAS - Targeting Eosinophils for Fewer Exacerbations: The Future of Biologic Treatments in COPD Management
|
Sep 20, 2024 |
|
Mark Awad, MD, PhD - Advancing the Therapeutic Landscape of SCLC with B7-H3–Targeted Antibody-Drug Conjugates: Insights and Future Directions
|
Sep 09, 2024 |
|
Leonard B. Bacharier, MD - Highlighting the Use of Biologics in Pediatric Patients: Case Scenarios to Elevate Asthma Treatment
|
Sep 09, 2024 |
|
Cecelia Damask, DO - Evidence-Based Approaches to Sequencing and Switching Biologic Therapies in Patients With CRSwNP and Comorbidities
|
Aug 16, 2024 |
|
Theresa W. Guilbert, MD, MS / William Anderson, MD - Optimizing Asthma Care in Pediatrics: The Impact of Early Intervention With Biologics on Lung Function
|
Aug 16, 2024 |
|
Eileen Wang, MD, MPH - Breathing Life Into Type 2 Asthma: Advancing Clinical Remission With Biologics
|
Aug 05, 2024 |
|
Luis Paz-Ares, MD, PhD - Exploring the Potential of TROP2 ADCs for Advanced/Metastatic NSCLC: Implications for Practice
|
Jul 12, 2024 |
|
Michael Thorpy, MD - Narcolepsy and Cardiovascular Health: Real-World Strategies to Enhance Long-Term Patient Outcomes
|
Jun 25, 2024 |
|
George L. Bakris, MD - On the Path to Improved Outcomes in Cardiorenal Disease: Strategies to Address Hyperkalemia and Maintain RAASi Therapy
|
Jun 18, 2024 |
|
Richard Bernstein, MD, PhD - Factoring a Balanced Efficacy and Safety Profile Into the Equation: Exploring FXIa Inhibitors in Stroke Prevention
|
Jun 18, 2024 |
|
Nick H. Kim, MD - Multimodal Management of Inoperable CTEPH: Evolving Therapeutic Strategies
|
May 15, 2024 |
|
Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician
|
Apr 05, 2024 |
|
Peter Lio, MD - Generative AI: Benefits for Your Practice, for Your Patients
|
Apr 05, 2024 |
|
Iacopo Olivotto, MD - A New Chapter in Hypertrophic Cardiomyopathy Management: Updates From the European Society of Cardiology (ESC) 2023 Guidelines and New Treatment Options
|
Mar 25, 2024 |
|
Heather Wakelee, MD - Stepping Up Clinical Outcomes for Resectable NSCLC: Examining the Role of Neoadjuvant Plus Adjuvant Immunotherapy Regimens
|
Mar 14, 2024 |
|
Vallerie V. McLaughlin, MD - Adding On Potential: Improving Treatment of Pulmonary Arterial Hypertension With Novel Add-On Therapies
|
Feb 26, 2024 |
|
Nicola A. Hanania, MD, MS - Enough: Targeting Eosinophilic Pathways With Biologics in Chronic Obstructive Pulmonary Disease
|
Jan 12, 2024 |
|
Michael Wechsler, MD - On the Case to Improve Outcomes in Uncontrolled Asthma: Best Practices to Enhance Clinical Care
|
Dec 29, 2023 |
|
Patrick Forde, MB, BCh - Keeping the Dialogue Open in Early-Stage NSCLC: Instituting a Multidisciplinary Approach
|
Dec 18, 2023 |
|
Jennifer Hill, MD - Breathing New Air Into Improved Outcomes: Strategies to Optimize Care in Patients With Uncontrolled Asthma
|
Dec 05, 2023 |
|
Vallerie V. McLaughlin, MD - Goal-Directed Therapy in PAH: Using Guideline-Recommended Sequential Combination Therapy Based on Risk Stratification to Optimize Patient Outcomes
|
Nov 13, 2023 |
|
Pam R. Taub, MD, FACC - Making the Case for Novel LDL-C–Lowering Therapies in the Management of Pediatric and Adult Homozygous Familial Hypercholesterolemia
|
Oct 09, 2023 |
|
Christopher P. Cannon, MD / Geetha Raghuveer, MD, MPH, MRCP - The Cholesterol Conversation: Early and Intensive Treatment of Homozygous Familial Hypercholesterolemia With Novel LDL-Lowering Strategies
|
Sep 19, 2023 |
|
Eric K. Singhi, MD / Charu Aggarwal, MD, MPH - It Takes Two to Tango: Exploring the Clinical Implications of First-Line Immunotherapy Plus Chemotherapy Combinations in Advanced NSCLC
|
Sep 05, 2023 |
|
Alexander I. Spira, MD, PhD, FACP - Breaking News in NSCLC: The Latest Evidence on Emerging Antibody Drug Conjugates Targeting TROP2
|
Sep 05, 2023 |
|
Jeffrey B. Geske, MD / Anjali Tiku Owens, MD - Expert Cardiology Perspectives in HCM: Slowing Disease Progression With Early Diagnosis and Integration of Cardiac Myosin Inhibitors
|
Aug 29, 2023 |
|
Jamie E. Chaft, MD - Enhancing Outcomes for Patients With Resected, Early-Stage NSCLC: A Piercing Evaluation of the Clinical Support for Adjuvant Immunotherapies
|
Aug 23, 2023 |
|
Bradley Chipps, MD - Calling the Shots for Pediatric Asthma Control: Integrating Biologics Into the Treatment Plan to Enhance Outcomes
|
Aug 17, 2023 |
|
Enriqueta Felip, MD, PhD / David Harpole, MD - Reflecting on the Role of Perioperative Immunotherapeutic Regimens for Resectable Non–Small-Cell Lung Cancer: Evaluating the Evidence to Determine Better Pathways of Care
|
Jul 27, 2023 |
|
Ticiana Leal, MD - Inspiring Improved Outcomes in Advanced NSCLC: A Patient-Centered Approach to Integrating Combination Locoregional and Immunotherapy Into Care
|
Jul 03, 2023 |
|
Kamala P. Tamirisa, MD, FACC, FHRS - Striving Toward Health Equity in Cardiovascular Disease: Patient-Centered Conversations to Address Social Determinants of Health in Nonvalvular Atrial Fibrillation
|
Apr 10, 2023 |
|
Pantelis Sarafidis, MD, MSc, PhD - Integrating Non-Steroidal Mineralocorticoid Receptor Antagonists Early in the Course of Disease: Practical Strategies for Patients With Early-Stage CKD and T2D
|
Mar 30, 2023 |
|
Giovanni L. Ceresoli - Advancing Care in Advanced Non–Small-Cell Lung Cancer With Combination Locoregional and Systemic Therapies
|
Mar 30, 2023 |
|
George L. Bakris, MD, MA / Paul P. Doghramji, MD, FAAFP - Enhancing Patient Outcomes in CKD: Recognizing the Importance of Early Detection and Optimized Management
|
Mar 27, 2023 |
|
Nicolas Girard, MD, PhD - Fortifying Outcomes in Unresectable Stage III Non–Small-Cell Lung Cancer: Current and Evolving Strategies to Optimize the Use of Consolidation Immunotherapy
|
Feb 15, 2023 |
|
Enriqueta Felip, MD, PhD - Breaking News for Frontline Dual Immunotherapy and Chemotherapy Combination Regimens: Improving Patient Outcomes in Advanced NSCLC
|
Jan 09, 2023 |
|
Nicola A. Hanania, MD, MS - Breathing With Ease in COPD: Patient-Centric Strategies to Improve Outcomes and Adherence With Triple Inhaler Therapy
|
Dec 29, 2022 |
|
Jennifer Green, MD - Integrating Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With CKD and T2D: Novel Strategies to Minimize Progression in Patients With Advanced Disease
|
Dec 29, 2022 |
|
Anne O'Donnell, MD - Diagnostic Imaging in Non-Cystic Fibrosis Bronchiectasis: The Radiologist's Role in Optimizing Care
|
Dec 29, 2022 |
|
Christoph Wanner, MD - Bringing the Treatment of Patients With CKD and T2D up to Speed: Synthesizing Guideline Updates and the Latest Data for Non-Steroidal Mineralocorticoid Receptor Antagonists
|
Dec 13, 2022 |
|
Theresa W. Guilbert, MD, MS - Blazing a Trail to Enhanced Outcomes for Children with Moderate-to-Severe Asthma: Practical Strategies to Incorporate Biologics
|
Dec 02, 2022 |
|
Matteo Bonini, MD, PhD - Maximizing Outcomes With Biologics: Gaining Control Over Uncontrolled Moderate-to-Severe Asthma in Children
|
Dec 02, 2022 |
|
Sandy Durrani, MD - Enhancing Control, Maximizing Outcomes: Advancements in Care for Children With Inadequately Controlled Asthma
|
Nov 28, 2022 |
|
Christopher P. Cannon, MD - On the Case to Reduce the Cumulative Burden of Elevated LDL-C in Patients With Severe Familial Hypercholesterolemia
|
Nov 15, 2022 |
|
LJ Tan, MS, PhD - RSV Vaccines in Older Adults: Emerging Prevention Strategies
|
Oct 28, 2022 |
|
Robert S. Rosenson, MD - Taking to Heart the Cumulative Burden of Elevated LDL Cholesterol: Clinical Strategies to Enhance Outcomes in Severe Familial Hypercholesterolemia
|
Oct 27, 2022 |
|
Mary O'Brien, MD, FRCP - Moving Immune Checkpoint Inhibitors to Resected Early-Stage Non-Small Cell Lung Cancer: Emerging Strategies for Adjuvant Therapy
|
Aug 12, 2022 |